Asset
Traxivitug
Vera Therapeutics Inc. Class A Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04294472 | phase2 | completed | 2020-08-05 | 2022-02-10 | Vera Therapeutics, Inc. | A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients |
FDA applications (0)
This company has no applications containing this asset.